Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL642105 | 0.83 | HCAR2 (0.54) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL642104 | 0.83 | HCAR2 (0.54) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL1964699 | 0.83 | HCAR2 (0.54) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL9860304 | 0.82 | HCAR2 (0.42) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL9860300 | 0.82 | HCAR2 (0.42) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL9861015 | 0.82 | HCAR2 (0.42) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL8405431 | 0.82 | HCAR2 (0.45) | HCAR2MAPTTSHRTP53EGLN1 | |
| SCHEMBL8405432 | 0.82 | HCAR2 (0.45) | HCAR2MAPTTSHRTP53EGLN1 | |
| Propane SCHEMBL7780510 | 0.81 | HCAR2 (0.54) | HCAR2MAPTTSHRTP53EGLN1 | |
| Methane SCHEMBL9860828 | 0.81 | HCAR2 (0.52) | HCAR2MAPTTSHRTP53EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5140013-A | Shelf life; polymerization inhibition; nontoxic; side effects reduction | UNIVERSITE LAVAL (CA) | 1992-08-18 | — | — | US | disclosed |
| WO-1991008775-A2 | MALEIC ANHYDRIDE DERIVATIVES USED AS CONJUGATION AGENTS OF ANTI-TUMOR AGENTS ON DESIRED CARRIERS | UNIVERSITE LAVAL (CA) | 1991-06-27 | — | — | WO | disclosed |